Most top-selling liver supplements on Amazon lack strong scientific evidence for safety or efficacy, with many relying on limited research.

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

HealthDay News — Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps ...

China has promised to give $500 million to WHO over the next 5 years, positioning itself to become the group’s top donor.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

The average annual national percentage change in mortality from hepatocellular carcinoma from 2005 to 2023 was higher for rural vs urban residents.

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

In a US cohort study, hospital inpatient diversity was linked to improved gastrointestinal outcomes in Hispanic and Native American patients.

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.